statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Quince Therapeutics just reported results for the fourth quarter of 2023.
The post QNCX Stock Earnings: Quince Therapeutics Reported...

QNCX Stock Earnings: Quince Therapeutics Reported Results for Q4 2023

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patients own biology to deliver rare disease...

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patients own biology to deliver rare disease...

Quince Therapeutics Launches Scientific Advisory Board

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

Quince Therapeutics to Participate at Investor Events in January 2024

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline consists of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.

Quince Therapeutics Inc

Volume	49,304.00
52-Wk High	$1.74
52-Wk Low	$0.84

Period	Estimated	Reported	Surprise	Result
Q1'23	--	-$0.31	--	N/A
Q4'22	--	-$0.29	--	N/A
Q3'22	-$0.28	-$0.28	--	EXPECTED
Q2'22	-$0.28	-$0.51	-81.97%	MISSED
Q1'22	-$0.55	-$0.72	-31.47%	MISSED

QNCX Quince Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals